Clinical Trial Update: Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update on immunogenicity and safety of a tetravalent meningococcal conjugate vaccine (A, C, Y, W135).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• Meningococcal A, C, Y and W-135 Conjugate Vaccine

Snippet

Sponsor: Beijing Minhai Biotechnology Co., Ltd | Conditions: Meningitis | Phase 3 | Status: COMPLETED